Maternal immunisation : collaborating with mother nature
Copyright © 2017 Elsevier Ltd. All rights reserved..
Maternal immunisation has the potential to substantially reduce morbidity and mortality from infectious diseases after birth. The success of tetanus, influenza, and pertussis immunisation during pregnancy has led to consideration of additional maternal immunisation strategies to prevent group B streptococcus and respiratory syncytial virus infections, among others. However, many gaps in knowledge regarding the immunobiology of maternal immunisation prevent the optimal design and application of this successful public health intervention. Therefore, we did an innovative landscape analysis to identify research priorities. Key topics were delineated through review of the published literature, consultation with vaccine developers and regulatory agencies, and a collaborative workshop that gathered experts across several maternal immunisation initiatives-group B streptococcus, respiratory syncytial virus, pertussis, and influenza. Finally, a global online survey prioritised the identified knowledge gaps on the basis of expert opinion about their importance and relevance. Here we present the results of this worldwide landscape analysis and discuss the identified research gaps.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:17 |
|---|---|
| Enthalten in: |
The Lancet. Infectious diseases - 17(2017), 7 vom: 01. Juli, Seite e197-e208 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Marchant, Arnaud [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Influenza Vaccines |
|---|
| Anmerkungen: |
Date Completed 10.07.2017 Date Revised 14.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/S1473-3099(17)30229-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM271201347 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM271201347 | ||
| 003 | DE-627 | ||
| 005 | 20231224232213.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S1473-3099(17)30229-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0904.xml |
| 035 | |a (DE-627)NLM271201347 | ||
| 035 | |a (NLM)28433705 | ||
| 035 | |a (PII)S1473-3099(17)30229-3 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Marchant, Arnaud |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Maternal immunisation |b collaborating with mother nature |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.07.2017 | ||
| 500 | |a Date Revised 14.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2017 Elsevier Ltd. All rights reserved. | ||
| 520 | |a Maternal immunisation has the potential to substantially reduce morbidity and mortality from infectious diseases after birth. The success of tetanus, influenza, and pertussis immunisation during pregnancy has led to consideration of additional maternal immunisation strategies to prevent group B streptococcus and respiratory syncytial virus infections, among others. However, many gaps in knowledge regarding the immunobiology of maternal immunisation prevent the optimal design and application of this successful public health intervention. Therefore, we did an innovative landscape analysis to identify research priorities. Key topics were delineated through review of the published literature, consultation with vaccine developers and regulatory agencies, and a collaborative workshop that gathered experts across several maternal immunisation initiatives-group B streptococcus, respiratory syncytial virus, pertussis, and influenza. Finally, a global online survey prioritised the identified knowledge gaps on the basis of expert opinion about their importance and relevance. Here we present the results of this worldwide landscape analysis and discuss the identified research gaps | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 7 | |a Influenza Vaccines |2 NLM | |
| 650 | 7 | |a Respiratory Syncytial Virus Vaccines |2 NLM | |
| 650 | 7 | |a Streptococcal Vaccines |2 NLM | |
| 700 | 1 | |a Sadarangani, Manish |e verfasserin |4 aut | |
| 700 | 1 | |a Garand, Mathieu |e verfasserin |4 aut | |
| 700 | 1 | |a Dauby, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Verhasselt, Valerie |e verfasserin |4 aut | |
| 700 | 1 | |a Pereira, Lenore |e verfasserin |4 aut | |
| 700 | 1 | |a Bjornson, Gordean |e verfasserin |4 aut | |
| 700 | 1 | |a Jones, Christine E |e verfasserin |4 aut | |
| 700 | 1 | |a Halperin, Scott A |e verfasserin |4 aut | |
| 700 | 1 | |a Edwards, Kathryn M |e verfasserin |4 aut | |
| 700 | 1 | |a Heath, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Openshaw, Peter J |e verfasserin |4 aut | |
| 700 | 1 | |a Scheifele, David W |e verfasserin |4 aut | |
| 700 | 1 | |a Kollmann, Tobias R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Lancet. Infectious diseases |d 2001 |g 17(2017), 7 vom: 01. Juli, Seite e197-e208 |w (DE-627)NLM117564362 |x 1474-4457 |7 nnns |
| 773 | 1 | 8 | |g volume:17 |g year:2017 |g number:7 |g day:01 |g month:07 |g pages:e197-e208 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S1473-3099(17)30229-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 17 |j 2017 |e 7 |b 01 |c 07 |h e197-e208 | ||